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Antimicrobial, Antioxidant and Antiproliferative Activities
of Novel Quinolones
Şule Ceylan,*[a] Yıldız Uygun Cebeci,[b] Neslihan Demirbaş,[b] Özge Özşen Batur,[c] and
Özlem Bingöl Özakpınar[d]
The compound (2) formed by esterification of dimethyl
morpholine (1) was converted to acetohydrazide (3). Subse-
quently Schiff bases (4a–d) and carboxy(thio)amide derivatives
(5a–e) were synthesized. Then 1,2,4-triazole (6a–e), thia(oxa)
zolidine (7c,e) and thia(oxa)zol (8c,e) derivatives were obtained
by ring closure from carboxy(thio)amides. Mannich bases,
which are containing quinolone were synthesized from 1,2,4-
triazoles. The structures of newly synthesized compounds were
illuminated by spectroscopic methods. Their antimicrobial (MIC
method), antioxidant (DPPH, FRAP, and CUPRAC methods), and
anticancer activities (MTT method) were examined. Results
showed that most of the compounds exhibited good anti-
microbial (<0.03–31.25 μg/mL with MIC values) and antiox-
idant activities (IC50=0.001–0.004 with DPPH values). Also,
some of the compounds have been found to have antiprolifer-
ative effects on the prostate (PC-3), liver (Hep3B), and breast
(MCF-7) human cancer cells, and also these compounds did not
have a cytotoxic effect on a normal cell.
Introduction
Cancer is the secondary reason of death after cardiovascular
illnesses and remains a great health issue worldwide.[1]
Infections with specific bacteria, viruses, and parasites have
been known as risk agents for different kinds of cancer in
humans.[2] Infection is the infestation of body organisms and
produced by illness agents which can be formed in a little
piece and effuse to the entire body.[3] The bacterial infection is
one of the most widespread infections both in society and in
hospitals, and it creates for a primary reason for sickly and
death rates in all world.[4,5] Antibiotics are very important for
the cure of bacterial infections.[6,7] But bacteria resistance has
occurred to nearly whole antibiotics because of the long-range
misuse of antibiotics.[8–10] To resolve this matter, it is urgent to
improve new molecules with high antimicrobial properties.
Hybrid compounds are molecules with two or more
structural fields, which have diverse dual activities and bio-
logical features. These substances generally possess the
capacity to get over medicine resistance, develop pharmacoki-
netic structures, and abate toxicity.[11,12]
Diverse investigators focus significantly on heterocyclic
compounds due to their multidirectional structure.[13] Hetero-
cycle groups, the part of many marketed medicines, is one of
the most significant pieces with antimicrobial activity in
modern medicine exploration.[14]
Morpholine is an organic molecule with a six-membered
ring in its structure and two heteroatoms such as oxygen and
nitrogen and it has been accepted as an important moiety in
medical chemistry. Morpholine is an ambidextrous nucleus as it
related to a large range of pharmacological activities. Morpho-
line derivatives are commonly used as antimicrobial, Anti-viral,
antidepressant, anticancer, anti-inflammatory, analgesics and
HIV-protease inhibitors, etc.[15–17]
Literature research showed that a lot of molecules contain-
ing five-membered rings such as triazoles and thiazoles display
substantial biological property. Molecules having 1,2,4-triazole
moiety show antibacterial.[18,19] Antifungal,[18,20] anti-
tubercular,[21] anti-inflammatory[22,23] activities. The thiazole
moiety also exists in different molecules with various pharma-
cological activities, such as antimicrobial,[24] anti-
inflammatory,[25] antitumoral.[26] Recently different novel sub-
stances with perfect activity towards both medicine-resistant
and medicine-sensitive pathogens have been improved by the
hybridization of 1,2,4-triazole with other antimicrobial pharma-
cophores.
Quinolines are widespread pharmacophores in the anti-
bacterial substances. Fluoroquinolones are noted as one of the
most broadly used antibacterial agents for the cure of bacterial
illness. Ciprofloxacin is a wide spectrum antibiotic that belongs
to the second generation of fluoroquinolone. It has been
confirmed for the cure of infections, particularly uretic system
infections, acute sinusitis, and chronic microbial prostatitis.[27–29]
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Thus, the hybridization of quinoline/quinolone with 1,2,4-
triazole is inclined to present hopeful anti-bacterial agents.[30,31]
Schiff bases are the molecules having imine parts (  C=N  ),
which are created by the condensation matters of aldehydes or
ketones together with primary amines. This kinds of products
are utilized as beginning materials in the reactions of
significant medicines.[32–34]
Literature showed that the Schiff bases have mostly
moderate to significant activities towards diverse microbial and
fungal strains.[35,36] Adding 1,2,4-Triazole in the Schiff bases
could efficiently develop its biological property, thus the
request and share of 1,2,4-triazole Schiff bases molecules in
pharmaceutical chemistry is growing.[37]
The aminomethylation synthesis is most generally utilized
for drug development studies and it results in the formation of
the so-called Mannich bases. The aminomethylation of aro-
matic substances by the Mannich reaction is of important
significance for the synthesis and modification of biologically
active molecules.[38] Recently Mannich bases have acquired
significance because of their practiced in medicinal chemistry.
They have been indicated to have analgesic and anti-
inflammatory,[39] antifungal, anticancer, antimicrobial,[40,41]
antitubercular,[42] activities.
The free radicals are responsible for most of the diverse
degenerative illnesses that affect humans. These contain
diabetes mellitus, inflammatory diseases, mild cognitive impair-
ment, cancer, Alzheimer’s disease, Parkinson’s disease, and
atherosclerosis.[43] Antioxidants can passive the free radicals
before they assault cells and biological materials to cause
different illnesses. Antioxidants are broadly researched for their
capability to preserve cells and organisms from harm that is
induced by oxidative stress. Scholars in many diverse fields
become more concerned novel molecules, either synthesized
or get from native resources that could supply active materials
to prevent or decrease the effect of oxidative stress on
cells.[44,45]
In this paper, we declared the synthesis of quinolones,
Schiff, and Mannich base derivatives containing 1,2,4-triazole
and morpholine rings. The newly obtained molecules were




The main goal of this paper was to improve antibacterial hybrid
molecules covering different pharmacophore groups. Reactions
of target and intermediate molecules were achieved as pictorial
in Scheme 1, Scheme 2, and Scheme 3. The finishing of the
synthesis was observed via the thin-layer chromatography
(TLC) process. All product structures were based on the
foundation of spectral and physicochemical data.
Antimicrobial Activity
All novel products were tested for their antibacterial activities
utilizing the minimal inhibition concentration method (MIC)
and the outcomes for active hybrid groups are summarized in
Table 1. The antimicrobial activities of compounds (2–9) were
tested against 4 bacteria and 3 yeasts. The microorganisms
selected for the antimicrobial activity studies are among
important plant and human pathogens and biofilm-producing
microorganisms and are targeted by many scientists in their
Scheme 1. Reactions and conditions. a: THF, ethyl bromoacetate, room temperature, 11 h; b: absolute ethanol, hydrazine hydrate, reflux for 7 h; c: absolute
ethanol, 2-hydoxy phenylaldehyde (for 4a) or, 2,4 dichloro benzaldehyde (4b) or, 4-methoxy phenylaldeyde (4c) or, indole-3-carbaldehyde (for 4d), reflux for
6 h: d: phenyl- (for 5a) or 4-fluorophenyl- (5b) or, benzyl- (5c) or, cyclohexyl isothiosyanate (5d) or, benzylisosyanate (for 5e), in dichloromethane, room
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recent studies. Table 1 shows the MIC ranges of compounds
(2–9) by broth microdilution for isolates. At the tested
concentrations, both compounds 2–9 did not show an
important antifungal activity (<250 μg/mL). Among the syn-
thesized compounds, compounds 2–8 displayed low-moderate
activity concerning test microorganisms (31.25–8000 μg/mL).
Mannich bases, 9b, 9c, 9d, 9f, 9g, 9h, and 9 i (<0.03 μg/
mL) strong antibacterial activities against Bacillus subtilis
NRRLB-4378 than compound 9e (0.24 μg/mL). And also com-
pounds 9b–i, (0.06–3.9 μg/mL) exhibited excellent antibacterial
activities against Staphylococcus aureus ATCC 6538, Salmonella
typhimurium ATCC 13311, and Escherichia coli ATCC 8739. These
antimicrobial reports are somewhat in agreement with some
previous results of obtained Mannich bases.[46,47]
Antioxidant Activity
The newly synthesized analogs were evaluated for their
antioxidant capacity by FRAP, CUPRAC, and DPPH techniques
(Table 2 and Figure 1). When the antioxidant studies of the
synthesized molecules were investigated, it was found that the
Carbothioamid derivatives 5a–c and Mannich base derivatives
9b, 9d, 9f, 9g, and 9h exhibited showed better activity. The
conclusions stated that the presence of quinolone and
carbothioamid groups may contribute to the antioxidant
activity. These conclusions also confirmed the result of the
antioxidant activities of some acquired Mannich bases.[48]
Among the synthesized compounds, the compound 9f has the
best activity according to the FRAP assay with a value of
1.126�0.037 μmol FeSO4.7H2O/g. And also compounds 5d, 5e,
6d, 7c, and 8e displayed good-moderate activity. For CUPRAC
assays the compound 5a has the most activity with the value
9.42�0.13 mmol TEAC/g. Accordingly results of the Cuprac
method, good activity was also observed for 5d and 6a–d
products compared to other compounds. Carbothioamid
derivatives 5a–c showed higher activities with IC50 values
0.004, 0.001 and 0.003 mg/mL, respectively in DPPH method
than standard Trolox (IC50=0.005). Thus they have also more
reducing properties. Also, 1,2,4-triazoles 6a–e, thiazol(idine)
derivatives 7c, 8c, and mannich bases 9b, 9d, 9g, 9h
displayed good-moderate activity for DPPH assay.
Antiproliferative Activity
The newly synthesized molecules were investigated for their
antiproliferative activity by the MTT method[49] and only the
values of the compounds that show good activity are shown in
the table (Table 3). Compounds were screened against 8
different human cancer cell lines. The anticancer screening
results at 10 μM concentration are summarized in Table 3 for
Mannich bases 9c, 9e, 9g, 9h, and 9 i with good activity.
Mannich base derivatives, 9c, 9e, 9g, 9h, and 9 i displayed
severe antiproliferative activity against prostate cancer, PC-3
(46.09%, 55.34%, 47.14%, 56.16%, and 48.79%, respectively)
Scheme 2. Reactions and conditions. a: absolute ethanol, sodium acetate, ethyl bromoacetate, reflux for 8 h; b: absolute ethanol, sodium acetate, 4-
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compared to imatinib mesylate, is a small molecule kinase
inhibitor used to treat certain types of cancer. On the other
hand, all compounds also have moderate or low antiprolifer-
ative activity against liver cancer, Hep3B. Moreover, it was
determined that this antiproliferative activity was more
effective than etoposide. There are many compounds synthe-
sized as anticancer products in the literature.[50,51]
Among these compounds, compound 9h showed the best
antiproliferative activity against three cancer cell lines (prostate,
liver, and breast cancers). Compound 9h showed cell growth
inhibition 56.16% for prostate adenocarcinoma cell line (PC-3),
41.16% for hepatocellular carcinoma cell line (Hep3B), and
41.72% for breast cancer cell line (MCF-7). The antiproliferative
activity studies were examined at the Marmara University,
Faculty of Pharmacy, Department of Biochemistry. Also,
whether or not compounds caused cytotoxic effects in non-
cancerogenic mouse embryonic fibroblast cell line (NIH-3T3)
was tested. Compounds showed no cytotoxicity effect on NIH-
3T3 cells.
Human myelogenous leukemia cell line, K562 (ATCC, CCL-
243), human Burkitt’s lymphoma cell line Raji (ATCC, CCL-86),
human lung adenocarcinoma cell line A549 (ATCC, CCL-185),
human prostate adenocarcinoma cell line, PC-3 (ATCC, CRL-
1435), human cervical adenocarcinoma cell line, HeLa (ATCC,
CCL-2), human breast cancer cell line MCF-7 (ATCC, HTB22),
human colon cancer cell line HT-29 (ATCC, HTB-38), human
hepatocellular carcinoma cell line, Hep3B (ATCC, HB-8064) and
non-cancerogenic mouse embryonic fibroblast cell line NIH-3T3
(ATCC, CRL-1658), bold values represent the cell lines selected
for cytotoxic studies.
Discussion
The synthesis of compound (2) has been acquired by the
reaction of dimethyl morpholine (1) with ethyl bromoacetate
and after that product (2) was transformed to the correspond-
ing hydrazide derivative (3). With the introduction of hydrazide
function in the molecule, two signals appeared at 4.19 and
8.91 ppm as D2O exchangeable singlets at the
1HNMR data of
the molecule (3).
Schiff bases (4a–4d) are obtained by reaction of hydrazide
compound (3) with various aromatic amines. In the FT IR data
of the azomethine function in the Schiff bases, HC=N groups
are revealed at 1600–1650 cm  1.[52,53] The view of singlet proton
of the azomethine function at 8.24–9.96 ppm in the 1H NMR
data supported the structures of Schiff bases acquired. The
Table 1. Antimicrobial activity of the compounds (μg/mL).
Comp.
No.
Minimal Inhibition Concentration Values (μg/mL)
Sa Bs St Ec Ca Cg Ck
2 4000 2000 125 1000 1000 – –
3 – 4000 250 1000 2000 – –
4a 4000 8000 2000 – – – –
4b – 8000 – 2000 2000 – –
4c 4000 2000 125 1000 1000 1000 1000
4d 4000 4000 250 4000 1000 2000 1000
5a – 8000 4000 – 1000 4000 –
5b 8000 8000 – – 2000 – 4000
5c 2000 1000 1000 2000 1000 2000 1000
5d 8000 – 8000 4000 4000 4000 4000
5e 4000 2000 – 250 8000 – 4000
6a 4000 4000 4000 4000 2000 4000 4000
6b 2000 8000 4000 4000 4000 4000 4000
6c 2000 2000 2000 2000 1000 2000 2000
6d 8000 – – 500 4000 4000 4000
6e 4000 4000 4000 4000 2000 4000 4000
7c 1000 31.25 4000 31.25 2000 4000 4000
7e – 2000 – – 4000 – 4000
8c – – 4000 1000 – – 4000
8e 4000 4000 4000 – 4000 – –
9b 0.12 <0.03 15.63 <0.03 4000 4000 4000
9c 0.49 <0.03 15.63 0.98 4000 4000 4000
9d 3.9 <0.03 31.25 0.49 4000 4000 4000
9e 1.95 0.24 15.63 0.98 4000 4000 4000
9f 0.24 <0.03 1.95 <0.03 500 4000 2000
9g 0.49 <0.03 1.95 0.24 – – –
9h 1.95 <0.03 3.9 <0.03 2000 4000 4000
9 i 0.06 <0.03 0.49 <0.03 4000 4000 4000
Chlor. 0.0019 0.0019 0.004 0.0156
Tetra. 0.0009 0.0009 0.0009 0.0019
Amf. B. 0.25 0.125 0.25
Fluc. 0.125 0.25 0.50
Sa: S. aureus ATCC 6538, Bs: B. subtilis NRRL B-4378, St: S. typhimurium ATCC 13311, Ec: E. coli ATCC 8739, Ca: C. albicans ATCC 90028, Cg: C. glabrata ATCC 2001,




11344ChemistrySelect 2020, 5, 11340–11346 © 2020 Wiley-VCH GmbH
Wiley VCH Dienstag, 29.09.2020
2036 / 180180 [S. 11344/11346] 1
protons of the hydroxyl group in the compound 4a were
revealed at 11.85 ppm. Aromatic protons were resonated in the
zone 6.82–7.98 ppm. In 13C NMR data of novel Schiff bases, the
carbon atom (HC=N) was showed between 126.81 and
152.81 ppm. Schiff bases achieved is the [M], [M+1], [M+2],
and [M+Na] ion signs displayed in the mass data of the
molecules.
Molecules (5a–e) were performed by the treatment of
molecule (3) with phenyl- (for 5a) or 4-fluorophenyl- (for 5b) or
benzyl- (for 5c), cyclohexyl isothiocyanate (for 5d) or benzyl
isocyanate (for 5e) in ethanolic solution in good yields and
molecule structures were approved via FT IR, 1H NMR, 13C NMR,
mass data.
The intramolecular cyclization of products (5a–e) at basic
media afforded in the transformation of carbox(thio)amide
function alter to 5-oxo(mercapto)-1,2,4-triazole derivatives and
so molecules 6a–e were synthesized. These compounds (6a–e)
were characterized by the presence of a signal at between
13.50–13.89 ppm in the 1H NMR data as a D2O exchangeable
singlet confirming the existence of a   SH function (6a–d) and
8.30 ppm   NH function (for 6e). The stretching band derived
from this group appeared at between 2510–2595 cm  1, and
C=0 (for 6e) observed at 1667 cm  1 at the FT-IR data of these
molecules (Scheme 1).
The synthesis of molecules (7c,e) and (8c,e) was carried out
by the treatment of compounds (5c,e) with ethyl bromoacetate
and 4-chlorophenacylbromide, respectively, and the structures
of these molecules were elucidated by spectroscopic techni-
ques such as 1H NMR, 13C NMR, FT-IR, and EI-MS. Also
synthesized molecules confirmed data results consistent with
the assigned structures (Scheme 2).
N-Mannich base derivatives have been utilized as poten-
tially helpful prodrug nominees for amines, imides, amides,
urea compounds, and hydantoin.[54] Mannich bases linked 1,2,4-
triazole derivatives as containing a significant biological activity
that has been reported in the literature.[54,55] Considering this
fact in this paper, the amino alkylation of structures (6b–e)
with different amines, such as norfloxacin (9b–e) or ciproflox-
acin (9 f–i) in an ambiance with formaldehyde was performed
Mannich synthesis reactions (Scheme 3). No signal symbolizing
the presence of the NH band exists on the 1H NMR and FT-IR
spectra of products (9b–i) and in the 1H NMR and 13C NMR
spectra of molecules extra signals originated from amine
moieties were observed at the concerned chemical ranges.
These molecules displayed mass spectral datum records
reasonable with their constructions.
Conclusions
This paper statements designed the synthesis of novel
molecules containing several bioactive units. Also, antibacterial,
antioxidant, and antiproliferative activity of the synthesized
molecules were investigated. Among the synthesized com-
pounds, the best activities (antibacterial, antioxidant, and
antiproliferative) were found to show compounds 9b–i which
are Mannich bases. According to antimicrobial results com-
pounds 9b–i displayed excellent activity on the test micro-








2 0.006�0.001 0.63�0.03 1.345
3 0.052�0.009 1.89�0.40 0.025
4a 0.014�0.009 3.66�0.31 0.544
4b 0.001�0.000 3.06�0.01 0.290
4c 0.018�0.003 2.44�0.10 13.329
4d 0.016�0.009 3.11�0.10 0.621
5a 0.055�0.001 9.42�0.13 0.004
5b 0.064�0.002 1.88�0.43 0.001
5c 0.021�0.000 1.02�0.01 0.003
5d 1.020�0.009 5.10�0.09 0.011
5e 1.006�0.030 0.71�0.26 1.481
6a 0.043�0.011 8.57�0.10 0.043
6b 0.022�0.002 6.38�0.94 0.066
6c 0.040�0.010 8.44�0.10 0.032
6d 1.081�0.064 7.23�0.40 0.063
6e 0.041�0.011 8.51�0.10 0.036
7c 1.015�0.029 3.51�0.31 0.080
7e 0.029�0.000 0.43�0.09 0.807
8c 0.119�0.040 0.90�0.01 0.033
8e 1.000�0.007 0.56�0.04 0.613
9b 0.006�0.002 1.31�0.42 0.155
9c 0.042�0.051 1.47�0.31 1.255
9d 0.006�0.001 2.14�0.08 0.411
9e 0.015�0.004 0.71�0.06 1.340
9f 1.126�0.037 2.53�0.21 1.255
9g 0.006�0.000 3.23�0.15 0.442
9h 0.002�0.000 2.44�0.15 0.373
9 i 0.041�0.003 1.26�0.08 1.170
Trolox – – 0.005
Table 3. Anticancer screening data at 10 μM concentration.
Cell Line Growth Inhibition (%)
9c 9e 9 g 9 h 9i İmatinib mesylate Etoposid
K562 0.95   5.25 26.74 14.22 12.58 41.35
Raji   21.78   20.61 16.91 23.26 14.91 39.58
A549   2.80 24.32 10.68 26.86 28.39 26.1
PC-3 46.09 55.34 47.14 56.16 48.79 34.52
HeLa   16.51   5.58   11.59 5.79   12.69 30.63
MCF-7 23.58 25.13 31.55 41.72 25.13   0.4
HT-29 6.71 4.34 15.68 19.53   4.48 3.64
Hep3B 32.54 27.59 38.65 41.16 32.26 6.03
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organisms, S. aureus, B. subtilis, S. typhimurium and E. coli. with
mic value between <0.03-31.25 mg/mL. In the antioxidant
capacity method which is DPPH, CUPRAC, and FRAP, 5a, 6d,
and 9f exhibited the best results. Mannich base derivatives 9c,
9e, 9g, 9h, and 9 i also have antiproliferative activity at rates
ranging from 41–56%. Besides compound 9h was the most
potent compound, and has been found anticancer effects on
the prostate (PC-3), liver (Hep3B), and breast (MCF-7) human
cancer cells, and also this compound did not have a cytotoxic
effect on a normal cell.
Supporting Information Summary
You will find the synthetic route, yields, melting points and
spectral data, and 1H NMR and 13C NMR spectra in the
Supporting Information file of newly synthesized compounds.
And also you will see the antimicrobial, antioxidant, and
anticancer activity determination methods.
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